Keyphrases
Optic Neuritis
100%
Multiple Sclerosis
84%
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
73%
Myasthenia Gravis
54%
Susac Syndrome
40%
Intravenous Immunoglobulin (IVIg)
37%
Israeli
29%
Multiple Sclerosis Treatment
27%
Obesity
27%
Depressive-like Behavior
27%
BNT162b2 COVID-19 Vaccine
27%
Oligoclonal Bands
27%
Israel
26%
Vaccination
25%
Brain-derived Neurotrophic Factor
25%
Methylprednisolone
23%
Intravenous Immunoglobulin Therapy
23%
Visual Outcome
18%
Adverse Events
18%
Steroid Treatment
17%
Clinical Characteristics
17%
Central Nervous System
17%
Diagnostic Criteria
17%
Chronic Mild Stress
16%
Factor Level
16%
Visual Acuity
16%
Myelin Oligodendrocyte Glycoprotein Antibody
16%
Corticosteroid Treatment
16%
Non-interventional
14%
Disease Diagnosis
14%
Multicenter Cohort Study
14%
Neuromyelitis Optica Spectrum Disorder (NMOSD)
13%
System Analysis
13%
Retrospective Analysis
13%
Postural Instability Gait Difficulty
13%
Fingolimod
13%
Cognitive Function
13%
Circulating T Cells
13%
Plastic Behavior
13%
Clinical Characterization
13%
Characterization Tests
13%
Large Cohort
13%
Parkinson's Disease
13%
Disease Outcome
13%
Early Safety
13%
Motor Subtypes
13%
Ventricular Arrhythmia
13%
Steroid-sparing
13%
Age-dependent Effects
13%
Young Animals
13%
Neuroscience
Optic Neuritis
85%
Multiple Sclerosis
68%
Myelin Oligodendrocyte Glycoprotein
61%
Myasthenia gravis
40%
Intravenous Immunoglobulin
40%
Brain-Derived Neurotrophic Factor
30%
Behavior (Neuroscience)
27%
Oligoclonal Band
27%
Cognitive Function
27%
Methylprednisolone
23%
Prednisone
20%
Myelin
20%
Central Nervous System
18%
Neurogenesis
16%
T Cell
16%
Anhedonia
16%
Hippocampus
16%
Light Chain
13%
Oligodendrocyte
13%
Fingolimod
13%
Diabetes Insipidus
13%
Magnetic Resonance Imaging
13%
Brain Plasticity
13%
Tremor
13%
Lumbar Puncture
13%
Parkinson's Disease
13%
Eicosanoid Receptor
8%
Montreal Cognitive Assessment
8%
Body Mass Index
7%
Aquaporin 4
7%
Demyelinating Disease
7%
Nucleus Accumbens
6%
Non-Motor Symptoms
6%
Propionic Acid
6%
Behavioral Effect
6%
Propionate
6%
Corticosterone
6%
Sensorineural Hearing Loss
6%
Brain Disease
6%
Nerve Fiber
6%
Neuromyelitis Optica
5%
Medicine and Dentistry
Multiple Sclerosis
56%
Optic Neuritis
54%
Susac Syndrome
54%
Disease
27%
Oligoclonal Band
27%
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
27%
Methylprednisolone
20%
Retrospective Study
19%
Magnetic Resonance Imaging
18%
Steroid Treatment
17%
Cerebrospinal Fluid
14%
Systematic Review
13%
COVID-19 Vaccine
13%
Homozygote
13%
Wolfram Syndrome
13%
Prednisone
13%
Plasma Exchange
13%
Lumbar Puncture
13%
COVID-19 Vaccination
13%
Immunoglobulin
13%
Hearing Impairment
10%
Diagnosis
10%
Diabetes
9%
Optic Nerve Atrophy
9%
Visual Impairment
8%
Immunosuppressive Drug
8%
Immunomodulation
8%
Clinically Isolated Syndrome
7%
Visual Acuity
7%
Disease Activity
6%
Retinal Nerve Fiber Layer
6%
Brain Disease
5%
Microaneurysm
5%
Deterioration
5%
Eye Disease
5%
Symptom
5%